Arterial plasma noradrenaline predicts left ventricular mass independently of blood pressure and body build in men who develop hypertension over 20 years
暂无分享,去创建一个
[1] Beretta-Piccoli,et al. Plasma Catecholamines and Essential Hypertension An Analytical Review , 2005 .
[2] A. Tannapfel,et al. Norepinephrine-Induced Changes in Cardiac Transforming Growth Factor-&bgr; Isoform Expression Pattern of Female and Male Rats , 2004, Hypertension.
[3] S. Oparil,et al. Alcohol consumption and cardiovascular risk in hypertensives with left ventricular hypertrophy: the LIFE study , 2004, Journal of Human Hypertension.
[4] M. Esler,et al. Sympathetic Augmentation in Hypertension: Role of Nerve Firing, Norepinephrine Reuptake, and Angiotensin Neuromodulation , 2004, Hypertension.
[5] M. Nieminen,et al. Losartan benefits over atenolol in non‐smoking hypertensive patients with left ventricular hypertrophy: The LIFE study , 2004, Blood pressure.
[6] K. Bailey,et al. Association of newer diastolic function parameters with age in healthy subjects: a population-based study. , 2003, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[7] M. Esler,et al. Relation Between Cardiac Sympathetic Activity and Hypertensive Left Ventricular Hypertrophy , 2003, Circulation.
[8] F. Rossi,et al. Aldosterone induces contraction of the resistance arteries in man. , 2003, Atherosclerosis.
[9] A. Struthers. Aldosterone: cardiovascular assault. , 2002, American heart journal.
[10] H. Dige-Petersen,et al. Is cardiovascular remodeling in patients with essential hypertension related to more than high blood pressure? A LIFE substudy. Losartan Intervention For Endpoint-Reduction in Hypertension. , 2002, American heart journal.
[11] J. Greenwood,et al. Hypertensive left ventricular hypertrophy: relation to peripheral sympathetic drive. , 2001, Journal of the American College of Cardiology.
[12] A. Pessina,et al. The Endothelin‐Aldosterone Axis and Cardiovascular Diseases , 2001, Journal of cardiovascular pharmacology.
[13] S. Kjeldsen,et al. Supine and exercise systolic blood pressure predict cardiovascular death in middle-aged men , 2001, Journal of hypertension.
[14] H. Baba,et al. Cardiac remodeling after long term norepinephrine treatment in rats. , 2001, Cardiovascular research.
[15] G. Mancia,et al. Adrenergic and Reflex Abnormalities in Obesity-Related Hypertension , 2000, Hypertension.
[16] M. Nieminen,et al. Left ventricular filling patterns in patients with systemic hypertension and left ventricular hypertrophy (the LIFE study) , 2000 .
[17] D. Levy,et al. Increased left ventricular mass and hypertrophy are associated with increased risk for sudden death. , 1998, Journal of the American College of Cardiology.
[18] S. Glasser. Hypertension, hypertrophy, hormones, and the heart. , 1998, American heart journal.
[19] J. Seward,et al. The noninvasive assessment of left ventricular diastolic function with two-dimensional and Doppler echocardiography. , 1997, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[20] L. Hatle,et al. Doppler evaluation of left and right ventricular diastolic function: a technical guide for obtaining optimal flow velocity recordings. , 1997, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[21] B. Strauer,et al. Left ventricular mass is linked to cardiac noradrenaline in normotensive and hypertensive patients , 1996, Journal of hypertension.
[22] J. Schwartz,et al. Association of carotid atherosclerosis and left ventricular hypertrophy. , 1995, Journal of the American College of Cardiology.
[23] N. Schork,et al. Sex‐Specific Determinants of Increased Left Ventricular Mass in the Tecumseh Blood Pressure Study , 1994, Circulation.
[24] H. Bjørnstad,et al. Left Ventricular Mass and Cardiovascular Reactivity in Young Men , 1994, Hypertension.
[25] S. Kjeldsen,et al. Cardiovascular reactivity, coronary risk factors, and sympathetic activity in young men. , 1993, Hypertension.
[26] K Rodahl,et al. Physical fitness as a predictor of mortality among healthy, middle-aged Norwegian men. , 1993, The New England journal of medicine.
[27] K. Weber,et al. Cardioreparation and the concept of modulating cardiovascular structure and function. , 1993, Blood pressure.
[28] J. Stewart,et al. Altered Function and Structure of the Heart in Dogs With Chronic Elevation in Plasma Norepinephrine , 1991, Circulation.
[29] D E Manyari,et al. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. , 1990, The New England journal of medicine.
[30] N. Schork,et al. Arterial plasma norepinephrine correlates to blood pressure in middle-aged men with sustained essential hypertension. , 1989, American heart journal.
[31] A. Tajik,et al. Assessment of diastolic function of the heart: background and current applications of Doppler echocardiography. Part II. Clinical studies. , 1989, Mayo Clinic proceedings.
[32] D. Levy,et al. Left ventricular mass and incidence of coronary heart disease in an elderly cohort. The Framingham Heart Study. , 1989, Annals of internal medicine.
[33] I. Hjermann,et al. Decreased central dopaminergic activity in essential hypertension. , 1987, Journal of hypertension.
[34] I. Hjermann,et al. Aging and urinary vasopressin excretion in healthy men. , 1987, Scandinavian journal of urology and nephrology.
[35] I. Hjermann,et al. Endocrine and haemodynamic responses to graded dopamine infusion in essential hypertension. , 1987, Scandinavian journal of clinical and laboratory investigation.
[36] J. Laragh,et al. Value of echocardiographic measurement of left ventricular mass in predicting cardiovascular morbid events in hypertensive men. , 1986, Annals of internal medicine.
[37] N. Reichek,et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. , 1986, The American journal of cardiology.
[38] I. Hjermann,et al. Evidence of age-related variation in plasma vasopressin of normotensive men. , 1985, Scandinavian journal of clinical and laboratory investigation.
[39] F. Dunn,et al. Clinical and hemodynamic determinants of left ventricular dimensions. , 1984, Archives of internal medicine.
[40] S. Kjeldsen,et al. Evidence of increased peripheral catecholamine release in patients with long-standing, untreated essential hypertension. , 1982, Scandinavian journal of clinical and laboratory investigation.
[41] A. DeMaria,et al. Recommendations Regarding Quantitation in M-Mode Echocardiography: Results of a Survey of Echocardiographic Measurements , 1978, Circulation.
[42] J. Peuler,et al. Simultaneous single isotope radioenzymatic assay of plasma norepinephrine, epinephrine and dopamine. , 1977, Life sciences.